These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6377080)

  • 1. A microautomated dilution method for susceptibility testing with antifungal drugs.
    Polonelli L; Morace G
    Mycopathologia; 1984 Apr; 86(1):21-8. PubMed ID: 6377080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique.
    Chen SC; O'Donnell ML; Gordon S; Gilbert GL
    J Antimicrob Chemother; 1996 Feb; 37(2):265-73. PubMed ID: 8707736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal susceptibility testing of yeast isolates from blood cultures by microbroth dilution and the E test.
    Simor AE; Goswell G; Louie L; Lee M; Louie M
    Eur J Clin Microbiol Infect Dis; 1997 Sep; 16(9):693-7. PubMed ID: 9352266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Morace G; Manzara S; Dettori G
    Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
    Warnock DW; Johnson EM; Rogers TR
    J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of reference procedures for broth microdilution antifungal susceptibility testing of yeasts with standardized endpoint determination.
    Makimura K; Sudo T; Kudo M; Uchida K; Yamaguchi H
    Microbiol Immunol; 1998; 42(1):55-9. PubMed ID: 9525781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Itraconazole vs amphotericin B: in vitro comparative evaluation of the minimal inhibitory concentration (MIC) against clinically isolated yeasts.
    Lombardi G; Gramegna G; Cavanna C; Poma G; Marangoni E; Michelone G
    Mycopathologia; 1989 Apr; 106(1):31-4. PubMed ID: 2549421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility testing of Cryptococcus neoformans using the urea broth microdilution method.
    Nakamura Y; Kano R; Watanabe S; Takahashi H; Hasegawa A
    Mycoses; 1998; 41(1-2):41-4. PubMed ID: 9610132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].
    Fujita S
    Rinsho Byori; 1996 Apr; 44(4):373-8. PubMed ID: 8847821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of a dried commercially prepared microdilution panel for antifungal susceptibility testing of five antifungal agents against Candida spp. and Cryptococcus neoformans.
    Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
    Diagn Microbiol Infect Dis; 2004 Oct; 50(2):113-7. PubMed ID: 15474320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified agar dilution susceptibility testing method for determining in vitro activities of antifungal agents, including azole compounds.
    Yoshida T; Jono K; Okonogi K
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1349-51. PubMed ID: 9174197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Etest method for determining isavuconazole MICs against Cryptococcus gattii and Cryptococcus neoformans.
    Thompson GR; Fothergill AW; Wiederhold NP; Vallor AC; Wickes BL; Patterson TF
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2959-61. PubMed ID: 18559645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of culture medium on susceptibility testing with BAY n 7133 and ketoconazole.
    Hoeprich PD; Merry JM
    J Clin Microbiol; 1986 Aug; 24(2):269-71. PubMed ID: 3528213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methods.
    Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2005 Aug; 43(8):3807-10. PubMed ID: 16081915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans.
    Pfaller MA; Messer SA; Hollis RJ; Jones RN
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2862-4. PubMed ID: 11557481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activity of dicationic aromatic compounds and fluconazole against Cryptococcus neoformans and Candida spp.
    Del Poeta M; Bixel AS; Barchiesi F; Tidwell RR; Boykin D; Scalise G; Perfect JR
    J Antimicrob Chemother; 1999 Aug; 44(2):223-8. PubMed ID: 10473229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a new commercial colorimetric microdilution method with a standard method for in-vitro susceptibility testing of Candida spp. and Cryptococcus neoformans.
    Davey KG; Szekely A; Johnson EM; Warnock DW
    J Antimicrob Chemother; 1998 Oct; 42(4):439-44. PubMed ID: 9818741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of antifungal activity of sertaconazole, terbinafine, and bifonazole against clinical isolates of Candida spp., Cryptococcus neoformans and dermatophytes.
    Carillo-Muñoz AJ; Tur-Tur C
    Chemotherapy; 1997; 43(6):387-92. PubMed ID: 9395851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antifungal activities of Bay n 7133 and Bay L 9139, two new orally absorbed antifungal imidazole derivatives, against pathogenic yeasts.
    Fromtling RA; Yu HP; Shadomy S
    Mycopathologia; 1984 Apr; 86(1):45-50. PubMed ID: 6330557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-site comparison of broth microdilution and semisolid agar dilution methods for susceptibility testing of Cryptococcus neoformans in three media.
    Anaissie E; Shawar R; Paetznick V; Ensign LG; Witte Z; LaRocco M
    J Clin Microbiol; 1993 May; 31(5):1370-2. PubMed ID: 8501245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.